Licensing Opportunities
A key element of Isconova's business model is to enter partnerships with pharmaceutical and biotechnology companies, that uses the ISCOM technology in new vaccines, large-scale antibody production and in other applications.
Convince yourself with the unparalleled performance of the product for your application using our license-free AbISCO® adjuvants in your research. For large-scale commercial use the technology is available for licensing.
If you consider licensing of Isconova's adjuvant technology, then please contact:
Mr. Bengt Falk, CEO
Phone: +46 18 57 24 00
Isconova's adjuvant technology is available for licensing in following application areas.
Convince yourself with the unparalleled performance of the product for your application using our license-free AbISCO® adjuvants in your research. For large-scale commercial use the technology is available for licensing.
If you consider licensing of Isconova's adjuvant technology, then please contact:
Mr. Bengt Falk, CEO
Phone: +46 18 57 24 00
Isconova's adjuvant technology is available for licensing in following application areas.
| Application area | Available applications |
|---|---|
| Human | All application areas for the Isconova Low-tox technology except Influenza |
| Horse | No applications available |
| Dog | All applications of all three generations of the ISCOM technology except 2 specific niche markets |
| Cat | All |
| Bovine | All applications except BRD - applications |
| Sheep | All |
| Bird / Avian | All |